Signal active
Investment Firm
Overview
They are fast entering a new age. A worldwide shift as significant as any in history. They call it The Cognitive Age. Combining the collective promise of science, technology and communication. And then making it accessible to all people.
Highlights
2007
Health Care
11-50
10
7
5
Early Stage Venture
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
NantCapital, established in 2007 and headquartered in United States, North America., specializes in Early Stage Venture investments across Information Services, Information Technology, Health Care, Hospital, Electronic Health Record (EHR), Biotechnology, Medical, Therapeutics, Genetics, Health Diagnostics. The organization boasts a portfolio of 10 investments, with an average round size of $87.6M and 5 successful exits. Their recent investments include Veradigm, Benitec Ltd, ImmunityBio, NantHealth, Highbridge Capital Management. The highest investment round they participated in was $13.1B. Among their most notable exits are Veradigm and Benitec Ltd. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
10
1
7
5
Investments
10
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Dec 12, 2022 | ImmunityBio | Health Care | 50.0M |
Mar 06, 2023 | NantHealth | Health Care | 22.5M |
Sep 11, 2023 | ImmunityBio | Health Care | 200.0M |
Sep 11, 2023 | ImmunityBio | Health Care | 270.0M |
Exits
5
Funding Timeline
10
0
0
Funding Rounds
10
NantCapital has raised 10 rounds. Their latest funding was raised on Sep 11, 2023 from a Post-IPO Equity - ImmunityBio round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Dec 12, 2022 | Post-IPO Debt - ImmunityBio | - | 50.0M | - |
Mar 06, 2023 | Post-IPO Debt - NantHealth | - | 22.5M | - |
Sep 11, 2023 | Post-IPO Debt - ImmunityBio | - | 200.0M | - |
Sep 11, 2023 | Post-IPO Equity - ImmunityBio | - | 270.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.